PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1997 March; 90(3): 122–123.
PMCID: PMC1296173

Growth hormone for adults.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (411K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • IKKOS D, LUFT R, GEMZELL CA. The effect of human growth hormone in man. Lancet. 1958 Apr 5;1(7023):720–721. [PubMed]
  • Salomon F, Cuneo RC, Hesp R, Sönksen PH. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 1989 Dec 28;321(26):1797–1803. [PubMed]
  • Jørgensen JO, Pedersen SA, Thuesen L, Jørgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS. Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet. 1989 Jun 3;1(8649):1221–1225. [PubMed]
  • Binnerts A, Swart GR, Wilson JH, Hoogerbrugge N, Pols HA, Birkenhager JC, Lamberts SW. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol (Oxf) 1992 Jul;37(1):79–87. [PubMed]
  • Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB, Hadden DR. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol (Oxf) 1992 Jan;36(1):45–52. [PubMed]
  • Cuneo RC, Salomon F, McGauley GA, Sönksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol (Oxf) 1992 Nov;37(5):387–397. [PubMed]
  • Rosén T, Johannsson G, Johansson JO, Bengtsson BA. Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. A review paper. Horm Res. 1995;43(1-3):93–99. [PubMed]
  • Bengtsson BA, Edén S, Lönn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tölli J, Sjöström L, Isaksson OG. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 1993 Feb;76(2):309–317. [PubMed]
  • Rosén T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990 Aug 4;336(8710):285–288. [PubMed]
  • JOHNSTON ID, HADDEN DR. Effect of human growth hormone on the metabolic response to surgical trauma. Lancet. 1963 Mar 16;1(7281):584–586. [PubMed]
  • Hadden DR, Rutishauser IH. Effect of human growth hormone in kwashiorkor and marasmus. Arch Dis Child. 1967 Feb;42(221):29–33. [PMC free article] [PubMed]
  • HADDEN DR, PROUT TE. A GROWTH HORMONE BINDING PROTEIN IN NORMAL HUMAN SERUM. Nature. 1964 Jun 27;202:1342–1343. [PubMed]
  • Baumann G, Stolar MW, Amburn K, Barsano CP, DeVries BC. A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab. 1986 Jan;62(1):134–141. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press